Samer Hussein
Chercheur universitaire
Axe Oncologie
Dernières nouvelles
Voir tout
Communiqués
La Fondation du CHU de Québec investit 1,2M$ pour propulser 13 projets d’envergure en recherche
Nouvelles
[Université Laval] Découverte d’une enzyme protectrice contre l’anémie de Fanconi
Nouvelles
[ULaval Nouvelles] Cancer de la prostate : des avancées du côté de la résistance aux traitements hormonaux
Publications
Voir tout-
article Daniele E, Khelifi G, Beretta D, Tsankov BK, Bang KWA, Beretta C, Philpott DJ, Hussein SM, Faiz M
ACSA2 is not astrocyte-specific: implications for cell sorting strategies in the rodent brain
Front Cell Neurosci 20 2026.
-
article Audet-Walsh É and Galey L, Renzi S, Morin N, Hussein SMI, Richer M, Huot MÉ
Combining anti-metabolic treatments with the repurposing of eribulin for glioblastoma: a clinical opportunity
Transl Cancer Res 14 (11), 2025.
-
article Segovia C, Desrosiers V, Khadangi F, Robitaille K, Armero VS, D'Astous M, Khelifi G, Bergeron A, Hussein S, Richer M, Bossé Y, Fradet Y, Fradet V, Bilodeau S
A versatile and efficient method to isolate nuclei from low-input cryopreserved tissues for single-nuclei transcriptomics
Sci Rep 15 (1), 2025.
Projets
- Unraveling the functional domains of a novel pluripotency-associated lncRNA, du 2023-04-01 au 2028-03-31
- Implications of RNA isoform diversity on gene function and cellular plasticity, du 2024-04-01 au 2029-03-31
- Targeting the sonic hedgehog medulloblastoma metabolic program for therapeutic purposes, du 2024-09-01 au 2026-08-31
- Support pour un projet structurant sur les cancers du cerveau, du 2024-11-15 au 2027-03-31
- New function for DEPTOR tyrosine 289 phosphorylation in glioma metabolism, du 2025-09-01 au 2027-08-31
- Platform for automated nucleic acid quality control and library preparation for next-generation sequencing, du 2026-03-31 au 2027-03-31
- Generation of a human induced pluripotent stem cell line containing a safe-harbour transgene insertion site, du 2026-02-01 au 2027-03-31
- Novel non-invasive gene therapy for Parkinson’s disease using viral encoded single-chain antibody treatment, du 2023-04-01 au 2024-09-30